Stories Related to Families Facing Rare Muscle Disease Are Pushing For An Experimental Gene Therapy, But The Fda Is Skeptical

SRP-9001, an experimental gene therapy that aims to slow or stop the progression of Duchenne muscular dystrophy, is being considered for accelerated approval by the FDA.

Topics:  health   
RELATED ARTICLES
    BING NEWS:
    • Heart failure is reversed with new gene therapy in animal study: ‘Unprecedented recovery’
      Heart failure has historically been irreversible, but a new study suggests that could change. At the University of Utah, scientists used a new gene therapy that reversed heart failure in animals.
      12/11/2024 - 1:26 am | View Link
    • UniQure shares soar on chance of speedy approval for Huntington’s therapy
      The company now says that, during a recent meeting with the FDA, the two parties agreed on some key elements for an accelerated approval application.
      12/10/2024 - 4:42 am | View Link
    • Promising gene therapy could transform heart failure treatment
      A new gene therapy can reverse the effects of heart failure and restore heart function in a large animal model.
      12/9/2024 - 11:24 pm | View Link
    • Breakthrough gene therapy offers new hope to child with muscular dystrophy
      Monroe Carell was a natural fit to offer the new therapy. Its multidisciplinary DMD Clinic, co-directed by Burnette, Soslow and pediatric pulmonologist Andrew Sokolow, MD, associate professor of ...
      12/8/2024 - 10:02 pm | View Link
    • More

     

    Welcome to Wopular!

    Welcome to Wopular

    Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

    Senh Duong (Founder)
    Wopular, MWB, RottenTomatoes

    Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

    MoviesWithButter : Our Sister Site

    More Health News